Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

CD4+T cells mediate protection against Zika associated severe disease in a mouse model of infection.

Hassert M, Wolf KJ, Schwetye KE, DiPaolo RJ, Brien JD, Pinto AK.

PLoS Pathog. 2018 Sep 13;14(9):e1007237. doi: 10.1371/journal.ppat.1007237. eCollection 2018 Sep.

2.

Mapping and Role of the CD8+ T Cell Response During Primary Zika Virus Infection in Mice.

Elong Ngono A, Vizcarra EA, Tang WW, Sheets N, Joo Y, Kim K, Gorman MJ, Diamond MS, Shresta S.

Cell Host Microbe. 2017 Jan 11;21(1):35-46. doi: 10.1016/j.chom.2016.12.010.

3.

CD4+ T cells promote humoral immunity and viral control during Zika virus infection.

Elong Ngono A, Young MP, Bunz M, Xu Z, Hattakam S, Vizcarra E, Regla-Nava JA, Tang WW, Yamabhai M, Wen J, Shresta S.

PLoS Pathog. 2019 Jan 24;15(1):e1007474. doi: 10.1371/journal.ppat.1007474. eCollection 2019 Jan. Erratum in: PLoS Pathog. 2019 May 28;15(5):e1007821.

4.

Dengue virus-reactive CD8+ T cells mediate cross-protection against subsequent Zika virus challenge.

Wen J, Elong Ngono A, Regla-Nava JA, Kim K, Gorman MJ, Diamond MS, Shresta S.

Nat Commun. 2017 Nov 13;8(1):1459. doi: 10.1038/s41467-017-01669-z.

5.

Vaccine protection against Zika virus from Brazil.

Larocca RA, Abbink P, Peron JP, Zanotto PM, Iampietro MJ, Badamchi-Zadeh A, Boyd M, Ng'ang'a D, Kirilova M, Nityanandam R, Mercado NB, Li Z, Moseley ET, Bricault CA, Borducchi EN, Giglio PB, Jetton D, Neubauer G, Nkolola JP, Maxfield LF, De La Barrera RA, Jarman RG, Eckels KH, Michael NL, Thomas SJ, Barouch DH.

Nature. 2016 Aug 25;536(7617):474-8. Epub 2016 Jun 28.

6.

CD8+ T Cell Immune Response in Immunocompetent Mice during Zika Virus Infection.

Huang H, Li S, Zhang Y, Han X, Jia B, Liu H, Liu D, Tan S, Wang Q, Bi Y, Liu WJ, Hou B, Gao GF, Zhang F.

J Virol. 2017 Oct 27;91(22). pii: e00900-17. doi: 10.1128/JVI.00900-17. Print 2017 Nov 15.

7.

Zika Virus Attenuation by Codon Pair Deoptimization Induces Sterilizing Immunity in Mouse Models.

Li P, Ke X, Wang T, Tan Z, Luo D, Miao Y, Sun J, Zhang Y, Liu Y, Hu Q, Xu F, Wang H, Zheng Z.

J Virol. 2018 Aug 16;92(17). pii: e00701-18. doi: 10.1128/JVI.00701-18. Print 2018 Sep 1.

8.

Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage.

Xu K, Song Y, Dai L, Zhang Y, Lu X, Xie Y, Zhang H, Cheng T, Wang Q, Huang Q, Bi Y, Liu WJ, Liu W, Li X, Qin C, Shi Y, Yan J, Zhou D, Gao GF.

J Virol. 2018 Feb 26;92(6). pii: e01722-17. doi: 10.1128/JVI.01722-17. Print 2018 Mar 15.

9.

Analysis of the T Cell Response to Zika Virus and Identification of a Novel CD8+ T Cell Epitope in Immunocompetent Mice.

Pardy RD, Rajah MM, Condotta SA, Taylor NG, Sagan SM, Richer MJ.

PLoS Pathog. 2017 Feb 23;13(2):e1006184. doi: 10.1371/journal.ppat.1006184. eCollection 2017 Feb.

10.

An Alanine-to-Valine Substitution in the Residue 175 of Zika Virus NS2A Protein Affects Viral RNA Synthesis and Attenuates the Virus In Vivo.

Márquez-Jurado S, Nogales A, Ávila-Pérez G, Iborra FJ, Martínez-Sobrido L, Almazán F.

Viruses. 2018 Oct 7;10(10). pii: E547. doi: 10.3390/v10100547.

11.

A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein.

Li A, Yu J, Lu M, Ma Y, Attia Z, Shan C, Xue M, Liang X, Craig K, Makadiya N, He JJ, Jennings R, Shi PY, Peeples ME, Liu SL, Boyaka PN, Li J.

Nat Commun. 2018 Aug 3;9(1):3067. doi: 10.1038/s41467-018-05276-4.

12.

From ZikV genome to vaccine: in silico approach for the epitope-based peptide vaccine against Zika virus envelope glycoprotein.

Alam A, Ali S, Ahamad S, Malik MZ, Ishrat R.

Immunology. 2016 Dec;149(4):386-399. doi: 10.1111/imm.12656. Epub 2016 Sep 7.

13.

Adenoviral vector type 26 encoding Zika virus (ZIKV) M-Env antigen induces humoral and cellular immune responses and protects mice and nonhuman primates against ZIKV challenge.

Cox F, van der Fits L, Abbink P, Larocca RA, van Huizen E, Saeland E, Verhagen J, Peterson R, Tolboom J, Kaufmann B, Schuitemaker H, Barouch DH, Zahn R.

PLoS One. 2018 Aug 24;13(8):e0202820. doi: 10.1371/journal.pone.0202820. eCollection 2018.

14.

A single-dose plasmid-launched live-attenuated Zika vaccine induces protective immunity.

Zou J, Xie X, Luo H, Shan C, Muruato AE, Weaver SC, Wang T, Shi PY.

EBioMedicine. 2018 Oct;36:92-102. doi: 10.1016/j.ebiom.2018.08.056. Epub 2018 Sep 7.

15.

A New In Vivo Model to Study Protective Immunity to Zika Virus Infection in Mice With Intact Type I Interferon Signaling.

Nazerai L, Schøller AS, Rasmussen POS, Buus S, Stryhn A, Christensen JP, Thomsen AR.

Front Immunol. 2018 Mar 22;9:593. doi: 10.3389/fimmu.2018.00593. eCollection 2018.

16.

Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses.

Tai W, He L, Wang Y, Sun S, Zhao G, Luo C, Li P, Zhao H, Fremont DH, Li F, Jiang S, Zhou Y, Du L.

Emerg Microbes Infect. 2018 Jan 24;7(1):7. doi: 10.1038/s41426-017-0007-8.

17.

Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors.

López-Camacho C, Abbink P, Larocca RA, Dejnirattisai W, Boyd M, Badamchi-Zadeh A, Wallace ZR, Doig J, Velazquez RS, Neto RDL, Coelho DF, Kim YC, Donald CL, Owsianka A, De Lorenzo G, Kohl A, Gilbert SC, Dorrell L, Mongkolsapaya J, Patel AH, Screaton GR, Barouch DH, Hill AVS, Reyes-Sandoval A.

Nat Commun. 2018 Jun 22;9(1):2441. doi: 10.1038/s41467-018-04859-5.

18.

Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans.

Grifoni A, Pham J, Sidney J, O'Rourke PH, Paul S, Peters B, Martini SR, de Silva AD, Ricciardi MJ, Magnani DM, Silveira CGT, Maestri A, Costa PR, de-Oliveira-Pinto LM, de Azeredo EL, Damasco PV, Phillips E, Mallal S, de Silva AM, Collins M, Durbin A, Diehl SA, Cerpas C, Balmaseda A, Kuan G, Coloma J, Harris E, Crowe JE Jr, Stone M, Norris PJ, Busch M, Vivanco-Cid H, Cox J, Graham BS, Ledgerwood JE, Turtle L, Solomon T, Kallas EG, Watkins DI, Weiskopf D, Sette A.

J Virol. 2017 Nov 30;91(24). pii: e01469-17. doi: 10.1128/JVI.01469-17. Print 2017 Dec 15.

19.

Amphiphilic block copolymer delivery of a DNA vaccine against Zika virus.

Hraber P, Bradfute S, Clarke E, Ye C, Pitard B.

Vaccine. 2018 Nov 12;36(46):6911-6917. doi: 10.1016/j.vaccine.2018.10.022. Epub 2018 Oct 15.

PMID:
30337177
20.

Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination.

Pardi N, Hogan MJ, Pelc RS, Muramatsu H, Andersen H, DeMaso CR, Dowd KA, Sutherland LL, Scearce RM, Parks R, Wagner W, Granados A, Greenhouse J, Walker M, Willis E, Yu JS, McGee CE, Sempowski GD, Mui BL, Tam YK, Huang YJ, Vanlandingham D, Holmes VM, Balachandran H, Sahu S, Lifton M, Higgs S, Hensley SE, Madden TD, Hope MJ, Karikó K, Santra S, Graham BS, Lewis MG, Pierson TC, Haynes BF, Weissman D.

Nature. 2017 Mar 9;543(7644):248-251. doi: 10.1038/nature21428. Epub 2017 Feb 2.

Supplemental Content

Support Center